Business · Companies · 1 hr ago
Judge approves Bayer’s $7.25 billion Roundup settlement
A Missouri judge approved Bayer’s $7.25 billion Roundup settlement on Friday.
The deal addresses lawsuits from people who say the weedkiller caused their cancer after they used it at home or at work.
It covers many current and future US claims, including claims from people later diagnosed with non-Hodgkin lymphoma.
Bayer denies that Roundup causes cancer and says studies show its active ingredient, glyphosate, is safe.
A US Supreme Court ruling in June weakened one major legal argument by limiting state claims that Bayer failed to warn customers about cancer.
The settlement is expected to provide compensation to many claimants, although some lawyers have argued that individual payments may be too low.
Some federal cases remain outside the settlement, and Bayer says about 200 are still being litigated.
A Missouri judge approved Bayer’s $7.25 billion settlement of US lawsuits alleging that its Roundup weedkiller causes cancer.
The nationwide settlement covers people already diagnosed with non-Hodgkin lymphoma and some who are diagnosed in the future.
Judge Timothy Boyer said the settlement was fair and adequate, while overruling objections that payments to victims were too low.
Bayer denies that Roundup causes cancer, and the settlement follows a US Supreme Court ruling that weakened some claims against the company.
- Who
- Bayer and people who used Roundup and have non-Hodgkin lymphoma, including some future patients.
- What
- A judge approved Bayer’s $7.25 billion settlement of US lawsuits over claims that Roundup causes cancer.
- When
- Friday, November 20, 2026.
- Where
- Missouri, United States.
- Why
- The settlement is intended to resolve nearly all current and future US Roundup claims and provide compensation to eligible claimants.
Roundup claimants and their lawyers
Bayer
Settlement adequacy
Roundup claimants and their lawyers
Some lawyers for claimants argued that individual payouts were too low.
Bayer
Bayer proposed the settlement to resolve litigation and reduce risks from current and future claims.
Cancer risk
Roundup claimants and their lawyers
Claimants allege Roundup caused cancer and say people should have been warned.
Bayer
Bayer denies that Roundup causes cancer and says it is safe.
Monsanto introduced Roundup, with glyphosate as its active ingredient.
Bayer acquired Monsanto, the producer of Roundup, for $63 billion.
The US Supreme Court ruled that federal pesticide law barred certain failure-to-warn claims brought under state law.
Judge Timothy Boyer approved Bayer’s $7.25 billion settlement in Missouri.
- Settlement amount
- $7.25 billion
- Eligible condition
- Non-Hodgkin lymphoma
- Individual settlement range
- $10,000 to $165,000
- Payment period
- Annual payments into a fund for up to 21 years
- Judge
- Timothy Boyer
- Roundup active ingredient
- Glyphosate
22 sources
Bayers Glyphosat-Sammelvergleich von Richter genehmigt
Bayer krijgt groen licht voor schikking $7,25 mrd in Roundup-zaak
Rechter in VS keurt miljardenschikking van Bayer met gebruikers Roundup goed
Rechter in VS keurt miljardenschikking goed van Bayer met gebruikers Roundup
Rechter in VS keurt miljardenschikking van Bayer goed met gebruikers Roundup
Judge approves $7.25bn settlement for Roundup weedkiller cancer claims
Bayer to pay $11b over claims weed killer caused cancer
Judge Approves $7 Billion Settlement Over Claims That Roundup Caused Cancer
Juez de EU avala acuerdo de Bayer por 7,025 millones de dólares para cerrar casos de herbicida Roundup
Court formally approves $7.25B class settlement for cancer claims from Roundup weed killer
Amerikaanse rechter keurt miljardenschikking Bayer over Roundup goed
Tribunal aprova acordo de US$ 7,25 bi com Bayer por acusação de câncer ligado a herbicida
Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
US judge approves $7.25 billion Roundup cancer settlement
Bayer’s $7.25bn settlement over cancer cases approved by US judge
Pharma: Bayers Glyphosat-Sammelvergleich von Richter genehmigt
Court Approves $7.25B Settlement With Bayer Over Claims Roundup Caused Cancer
Corte aprueba acuerdo de 7.250 millones de dólares con Bayer por demandas sobre herbicida y cáncer
Bayer: Gericht genehmigt milliardenschweren Glyphosat-Vergleich
Bayer acepta pagar 7.250 millones de dólares en EEUU para cerrar la demanda colectiva que vincula su herbicida Roundup con el cáncer
Langer Rechtsstreit: Bayers Glyphosat-Sammelvergleich von Richter genehmigt
Bayer’s $7.25 Billion Roundup Settlement Approved by Judge
What people are saying
fair, reasonable, and adequate
The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation
We look forward to getting this relief into the hands of all Roundup victims as quickly as possible
Today's final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.